MAPT and Alzheimer disease: The preclinical results from this study show that the neuroprotective effects offered by 12A12mAb delivery on the eyes from Tg2576 AD model (Fig. 8) are paralleled by the contextual improvement in hippocampal-dependent cognitive functions owing to antibody-mediated paired reduction of the 20–22 kDa tau fragment [57].